NO304409B1 - Synergetic antimalarial compositions containing bone flumetol - Google Patents

Synergetic antimalarial compositions containing bone flumetol

Info

Publication number
NO304409B1
NO304409B1 NO933271A NO933271A NO304409B1 NO 304409 B1 NO304409 B1 NO 304409B1 NO 933271 A NO933271 A NO 933271A NO 933271 A NO933271 A NO 933271A NO 304409 B1 NO304409 B1 NO 304409B1
Authority
NO
Norway
Prior art keywords
flumetol
synergetic
compositions containing
antimalarial
containing bone
Prior art date
Application number
NO933271A
Other languages
Norwegian (no)
Other versions
NO933271L (en
NO933271D0 (en
Inventor
Anton Alexander Poltera
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1993/000163 external-priority patent/WO1993015727A1/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO933271L publication Critical patent/NO933271L/en
Publication of NO933271D0 publication Critical patent/NO933271D0/en
Publication of NO304409B1 publication Critical patent/NO304409B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

FIELD: chemical-pharmaceutical industry. SUBSTANCE: invention relates to pharmaceutical composition showing activity with respect to malaria. Composition has SYNERGISTIC ANTIMALARIAL component containing ANTIMALARIAL agent benflulatol and ANTIMALARIAL agent from quinine group, for example, quinine. EFFECT: enhanced effectiveness of composition. 3 cl, 2 tbl, 6 dwg
NO933271A 1992-02-07 1993-09-14 Synergetic antimalarial compositions containing bone flumetol NO304409B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP92810089 1992-02-07
EP92810130 1992-02-21
PCT/EP1993/000163 WO1993015727A1 (en) 1992-02-07 1993-01-25 Antimalarial synergistic compositions containing benflumetol

Publications (3)

Publication Number Publication Date
NO933271L NO933271L (en) 1993-09-14
NO933271D0 NO933271D0 (en) 1993-09-14
NO304409B1 true NO304409B1 (en) 1998-12-14

Family

ID=26132495

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933271A NO304409B1 (en) 1992-02-07 1993-09-14 Synergetic antimalarial compositions containing bone flumetol

Country Status (6)

Country Link
AT (1) ATE177631T1 (en)
DE (1) DE69323941T2 (en)
ES (1) ES2130250T3 (en)
NO (1) NO304409B1 (en)
OA (1) OA10057A (en)
RU (1) RU2118158C1 (en)

Also Published As

Publication number Publication date
NO933271L (en) 1993-09-14
NO933271D0 (en) 1993-09-14
RU2118158C1 (en) 1998-08-27
ATE177631T1 (en) 1999-04-15
ES2130250T3 (en) 1999-07-01
OA10057A (en) 1996-10-14
DE69323941T2 (en) 1999-08-26
DE69323941D1 (en) 1999-04-22

Similar Documents

Publication Publication Date Title
EA199700277A1 (en) PHARNESIL-PROTEINTRANSFERASE INHIBITING COMPOUNDS AND PHARMACEUTICAL COMPOSITION ON THEIR BASIS
EA199800772A1 (en) Derivatives of 6-phenylpyridyl-2-amine
MX9202181A (en) BIS MONO AND BICYCLIC ARYLIC AND HETEROARILIC COMPOUNDS INHIBITING EGF AND / OR PDGF RECIPIENT THYROSINE KINASE.
PT750618E (en) OXAZOLIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
BR9814327A (en) Thiourea and benzamide compounds, compositions and processes for the treatment or prevention of inflammatory diseases and arteriosclerosis
ATE245977T1 (en) THERAPEUTIC SUBSTITUTED GUANIDINES
PT661992E (en) PHARMACEUTICAL FORMULATIONS OF INTERLEUCIN-1 INHIBITORS
DE69837324D1 (en) TREATMENT OF MULTIPLE SCLEROSIS BY USING COPOLYMER-1
PT741716E (en) ANALOGOS OF DELTA 12,13-ISO-TAXOL ITS ANTI-NEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
DK0964687T3 (en) Pharmaceutical compositions with antimicrobial activity
EA200000165A1 (en) BRANCHED ALCOXYLENE-2-AMINOPYRIDINES AS NOS INHIBITORS
NO304409B1 (en) Synergetic antimalarial compositions containing bone flumetol
MX9203361A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING GALIUM CHLORIDE.
EA200100956A1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON TIZOXANIDE AND NITAZOXANIDE
AR019817A1 (en) MULTIADHERENT COMPOUNDS, USE OF SUCH COMPOUNDS TO PREPARE A USEFUL MEDICINAL PRODUCT TO TREAT MAMIFERS THAT HAVE A DISEASE THAT IS RELIEFED BY TREATMENT WITH AN ANTIBACTERIAL AGENT, PROCEDURE FOR THE PREPARATION OF THESE COMPOUND COMPOSITIONS AND COMPOSITION
FR2381034A1 (en) ANALGESIC AND ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS BASED ON 1,3,5-TRIAZINE
SE8403659D0 (en) SYNERGISTIC PHARMACEUTICAL COMPOSITION
ATE193206T1 (en) COMPOSITION FOR TREATING OR PREVENTING HERPES
ATE100713T1 (en) L-ALPHA-GLYCEROPHOSPHORYL-D-MYOINOSITOL FOR THE TREATMENT OF PERIPHERAL NEUROPATHIES AND CEREBROPATHIES.
ES2179667T3 (en) NEW INJECTABLE FORMULATIONS CONTAINING RAMOPLANIN.
FI914410A0 (en) CALCIUMUPPTAGANDE INHIBITORER.
BR0009113A (en) Pharmaceutical composition on the basis of polychromatic compounds
SE8303886L (en) SYNERGETIC ANTIHYPERTENSIVE PHARMACEUTICAL COMPOSITION
RU93058291A (en) ANTIMALERIC SYNERGETIC COMPOSITIONS CONTAINING BENFLUMETOL
GEP19991586B (en) Pharmaceutical Formulation

Legal Events

Date Code Title Description
MK1K Patent expired